person · Reporting owner
KIRITSY CHRISTOPHER P
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INCHTGM · Entity 112530 | Director | September 15, 2022 | September 15, 2022 |
| PALVELLA THERAPEUTICS, INC.PVLA · Entity 4452 | Director | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HTG MOLECULAR DIAGNOSTICS, INC
Report date September 15, 2022 · Filed September 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.86 · Expires 2032-09-14 | Direct | 4,000 |
Reported balance
After 2022-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-09-15 · Grant · Acquired 4,000 · Balance 4,000 F1: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders.
PALVELLA THERAPEUTICS, INC.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 563 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Exercise / conversion · Acquired 313 · Balance 563 F1: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 250 |
Reported balance
After 2026-09-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-02 · Sale · Disposed 313 · Balance 250 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $127.20 · Expires 2026-09-20 | Direct | 0 |
Reported balance
After 2026-09-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-02 · Exercise / conversion · Disposed 313 · Balance 0 F1: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F2: The stock option is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024.
F2: The stock option is fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | Exercise / conversionStock Option (Right to Buy) · Derivative | 313 | $0.00 Strike: $127.20 | $0.00 |
DisclosureSEC source: 0001104659-26-105494 · tm2624833-1_4seq1.xml · derivative · entry 3 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 313 shares Expires 2026-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F1 · kind: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F1 · shares: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F2 · derivative.exercise_date: The stock option is fully vested. F1 · derivative.underlying_shares: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | SaleCommon Stock | 313 | $157.00 | $49,141.00 |
DisclosureSEC source: 0001104659-26-105494 · tm2624833-1_4seq1.xml · nonDerivative · entry 2 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | Exercise / conversionCommon Stock | 313 | $127.20 | $39,813.60 |
DisclosureSEC source: 0001104659-26-105494 · tm2624833-1_4seq1.xml · nonDerivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F1 · price: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. F1 · balance_after: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:07 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $102.19 | $0.00 |
DisclosureSEC source: 0001104659-26-073443 · tm2617372-6_4seq1.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2036-06-10 F1 · derivative.exercise_date: The shares subject to this option shall vest upon the earlier of (i) the first anniversary of the grant date or (ii) the date of the Issuer's next annual meeting of stockholders following the grant date, subject in each case to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 19:59 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,350 | $0.00 Strike: $26.23 | $0.00 |
DisclosureSEC source: 0001583648-25-000041 · edgardoc.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,350 Underlying: Common Stock · 12,350 shares Expires 2035-06-10 Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 20:40 UTC | PALVELLA THERAPEUTICS, INC. PVLA · Entity 4452 | GrantStock Option (right to buy) · Derivative | 24,700 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001062993-24-020815 · form4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,700 Underlying: Common Stock · 24,700 shares Expires 2034-12-13 F1 · derivative.exercise_date: The stock options will vest and become exercisable in 36 equal monthly installments through the third anniversary of the grant date. Read SEC document |
| December 02, 2024 Filed Dec 9, 2024 07:32 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0001437749-24-036916 · rdgdoc.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2034-12-02 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on December 2, 2025, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 16:46 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001437749-23-018281 · rdgdoc.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:21 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | PurchaseCommon Stock | 10,000 | $0.85 | $8,500.00 |
DisclosureSEC source: 0001562180-23-004575 · primarydocument.xml · nonDerivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| September 15, 2022 Filed Sep 15, 2022 18:15 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-22-050150 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2032-09-14 F1 · derivative.exercise_date: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 19:03 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001583648-22-000050 · wf-form4_165611176500631.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on the date of the Company's 2023 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:46 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-22-005588 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-01-26 F1 · derivative.exercise_date: One-third of the shares will vest twelve months after January 27, 2022 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of January 27, 2022. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:30 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004561 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-06-25 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on the date of the Company's 2022 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 17:05 UTC Amendment | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.27 | $0.00 |
DisclosureSEC source: 0001562180-20-004696 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-06-23 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on June 23, 2021, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:45 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.27 | $0.00 |
DisclosureSEC source: 0001562180-20-004689 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-01-23 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on June 23, 2021, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| January 25, 2020 Filed Jan 28, 2020 16:20 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001562180-20-000621 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-01-25 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on January 25, 2021, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 17:40 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001562180-19-000577 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-25 F1 · derivative.exercise_date: The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 17:42 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | PurchaseCommon Stock | 5,000 | $5.11 | $25,525.00 |
DisclosureSEC source: 0001562180-18-003953 · primarydocument.xml · nonDerivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.05 to $5.15, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 16:40 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.72 | $0.00 |
DisclosureSEC source: 0001562180-18-000484 · primarydocument.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018. Read SEC document |
| April 21, 2017 Filed May 9, 2017 18:30 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0000899243-17-012544 · doc4.xml · derivative · entry 2 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. Read SEC document |
| April 21, 2017 Filed May 9, 2017 18:30 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | Exercise / conversionCommon Stock | 5,000 | $1.59 | $7,950.00 |
DisclosureSEC source: 0000899243-17-012544 · doc4.xml · nonDerivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2017 Filed Jan 30, 2017 19:10 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000899243-17-002209 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-25 F1 · derivative.exercise_date: The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 10:44 UTC | PALVELLA THERAPEUTICS, INC. PIRS · Entity 4452 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0000899243-16-029695 · doc4.xml · derivative · entry 1 KIRITSY CHRISTOPHER P · CIK 0001261156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-20 F1 · security: The stock option will vest in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. F1 · derivative.exercise_date: The stock option will vest in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.